| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |